Jiangsu Coben Pharmaceutical

Jiangsu Coben Pharmaceutical is a China-based pharmaceutical manufacturing company focused on small-molecule pharmaceutical intermediates, active pharmaceutical ingredients, and some finished dosage products. The company operates as an integrated manufacturer spanning intermediates, APIs, and formulations, with a product portfolio that includes antivirals, cardiovascular drugs, antifungals, metabolic disease products, and oncology-related compounds. Publicly visible catalogs emphasize commercial supply of APIs and intermediates such as sofosbuvir, tenofovir alafenamide hemifumarate, ticagrelor, tranexamic acid, oseltamivir, apremilast, relugolix, darolutamide, alectinib, and resmetirom-related products. Available evidence suggests the business is primarily a manufacturing and export-oriented pharma supplier rather than an innovation-driven clinical-stage biotech company. The company appears to be active and based in Qidong, Jiangsu, China.